A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Investigational Site Number : 0560003, Edegem

Investigational Site Number : 0560001, Leuven

Investigational Site Number : 3800001, Rozzano

Investigational Site Number : 3800003, Milan

Investigational Site Number : 3800002, Milan

Investigational Site Number : 7240003, Madrid / Madrid

Investigational Site Number : 7240101, Madrid

Investigational Site Number : 7240004, Madrid / Madrid

Investigational Site Number : 2500006, Brest

Investigational Site Number : 7240001, Pamplona

AdventHealth Orlando Site Number : 8400005, Orlando

Investigational Site Number : 2500004, Bordeaux

Investigational Site Number : 7240005, Santander

Investigational Site Number : 2500002, Paris

Investigational Site Number : 2500005, Poitiers

City of Hope Site Number : 8400007, Duarte

Investigational Site Number : 2500001, Villejuif

Seattle Cancer Care Alliance Site Number : 8400009, Seattle

Investigational Site Number : 1560002, Wuhan

Investigational Site Number : 1520001, Santiago

Investigational Site Number : 0560002, Brussels

Investigational Site Number : 5280001, Amsterdam

Investigational Site Number : 5280003, Rotterdam

Investigational Site Number : 4100002, Seoul

Investigational Site Number : 4100004, Seoul

Investigational Site Number : 4100001, Seoul

Investigational Site Number : 4100003, Seoul

Investigational Site Number : 7240002, Barcelona

Investigational Site Number : 7240006, Barcelona